Suppr超能文献

基因中荷兰p16-创始变体的体细胞镶嵌现象的一个意外病例。

An Unexpected Case of Somatic Mosaicism of the Dutch p16- Founder Variant in the Gene.

作者信息

van der Meulen M, van Wezel J T, Terlouw D, Morreau J, Steeghs E M P, van Doorn R, van Leerdam M E, Onnekink A M, de Ruiter M C, van der Stoep N, Potjer T P

机构信息

Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.

Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.

出版信息

Case Rep Genet. 2025 Aug 28;2025:6261903. doi: 10.1155/crig/6261903. eCollection 2025.

Abstract

is the primary high-risk predisposition gene for familial cutaneous melanoma. In the Netherlands, most carriers of pathogenic germline variants in harbor a unique, population-specific founder variant, c.225_243del, commonly referred to as p16-. For decades, this distinctive 19 base-pair deletion in had been identified exclusively as a germline variant. Here, we report an exceptional case of somatic mosaicism for the p16- variant in an Irish male with a concurrent diagnosis of Kartagener's syndrome but no history of malignancy. The variant was first identified through targeted next-generation sequencing (NGS) of a fundic gland polyp in the distal esophagus, showing a variant allele frequency (VAF) of 40%. Subsequent analysis also detected the variant in the patient's buccal swab DNA (VAF 0.3%), while it was notably absent in multiple other tissue samples, including blood, urine, skin, and several additional samples from the proximal gastrointestinal tract. We explore several hypotheses that could explain these intriguing findings.

摘要

是家族性皮肤黑色素瘤的主要高风险易感基因。在荷兰,大多数携带该基因致病种系变异的人都有一个独特的、特定人群的奠基者变异,即c.225_243del,通常称为p16-。几十年来,该基因中这种独特的19个碱基对缺失一直仅被鉴定为种系变异。在此,我们报告了一例爱尔兰男性中p16-变异的体细胞镶嵌现象的特殊病例,该男性同时被诊断为卡塔格内综合征,但无恶性肿瘤病史。该变异首先通过对远端食管胃底腺息肉进行靶向二代测序(NGS)发现,变异等位基因频率(VAF)为40%。后续分析在患者的口腔拭子DNA中也检测到了该变异(VAF为0.3%),而在包括血液、尿液、皮肤以及近端胃肠道的其他多个组织样本中则明显未检测到。我们探讨了几种可以解释这些有趣发现的假说。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e5/12411021/5ec9b4eebf6c/CRIG2025-6261903.001.jpg

本文引用的文献

1
Genetic Signature of Human Pancreatic Cancer and Personalized Targeting.
Cells. 2024 Mar 29;13(7):602. doi: 10.3390/cells13070602.
2
Genetic testing for familial melanoma.
Ital J Dermatol Venerol. 2024 Feb;159(1):34-42. doi: 10.23736/S2784-8671.23.07761-7. Epub 2024 Jan 29.
3
A genomic mutational constraint map using variation in 76,156 human genomes.
Nature. 2024 Jan;625(7993):92-100. doi: 10.1038/s41586-023-06045-0. Epub 2023 Dec 6.
4
Craniofacial developmental biology in the single-cell era.
Development. 2023 Oct 1;150(19). doi: 10.1242/dev.202077. Epub 2023 Oct 9.
5
Pan-cancer whole-genome comparison of primary and metastatic solid tumours.
Nature. 2023 Jun;618(7964):333-341. doi: 10.1038/s41586-023-06054-z. Epub 2023 May 10.
7
Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your Eyes.
Biomedicines. 2022 Aug 29;10(9):2118. doi: 10.3390/biomedicines10092118.
9
Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic variants.
J Med Genet. 2021 Apr;58(4):264-269. doi: 10.1136/jmedgenet-2019-106562. Epub 2020 Jun 1.
10
Optical detection of field cancerization in the buccal mucosa of patients with esophageal cancer.
Clin Transl Gastroenterol. 2018 Apr 30;9(4):152. doi: 10.1038/s41424-018-0023-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验